
Nathan Charles Bahr MD MS-CR, FIDSA (He/Him)
HIV/AIDS Medicine, International Health, Travel & Tropical, Mycobacterial Disease
Associate Professor at the University of Minnesota
Join to View Full Profile
420 Delaware St SEMinneapolis, MN 55455
Phone+1 612-624-9996
Dr. Bahr is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am an associate professor of Infectious disease at the University of Minnesota. My current research centers on improving diagnostics for TB meningitis and histoplasmosis as well as improving care, evaluating novel therapies and minimizing treatment toxicity for patients with Cryptococcal meningitis and TB meningitis.
Education & Training
- University of Kansas School of MedicineFellowship, Infectious Disease, 2015 - 2016
- University of MinnesotaFellowship, Infectious Disease, 2013 - 2015
- National Institutes of Health - Fogarty International CenterFellow, Tuberculosis Meningitis, Cryptococcal Meningitis, 2013 - 2014
- University of MinnesotaChief Residency, Internal Medicine, 2012 - 2013
- University of MinnesotaResidency, Internal Medicine, 2009 - 2012
- Loyola University Chicago Stritch School of MedicineClass of 2009
Certifications & Licensure
- MN State Medical License 2023 - 2026
- KS State Medical License 2016 - 2024
- MO State Medical License 2021 - 2024
- American Board of Internal Medicine Infectious Disease
- ASTMHCTropmed
Publications & Presentations
PubMed
- Diagnostic accuracy of the re-engineered urinary FujiLAM2 assay amongst hospitalized adults with advanced HIV disease: a prospective cohort study.Jayne Ellis, Biyue Dai, Mable Kabahubya, Gila Hale, Emmanuel Mande
AIDS. 2025-04-22 - Etiology and Outcomes of Meningitis among Adults in Three Ugandan Referral Hospitals, 2018-2023: A Prospective Cohort Study in a High-HIV Endemic Setting.Timothy Mugabi, Suzan Namombwe, Biyue Dai, Elizabeth Nalintya, Laura J Nsangi
The American Journal of Tropical Medicine and Hygiene. 2025-04-15 - Evolving Epidemiology, Improving Diagnostic Tests and Their Importance for the Correct Diagnosis of Histoplasmosis.Thomas E Schmidt, Tarsila Vieceli, Lisandra Serra Damasceno, Sarah Kimuda, Alessandro C Pasqualotto
Journal of Fungi. 2025-03-04
Press Mentions
- Kansas Health Experts Monitoring COVID-19, Flu and RSV Trifecta as Holiday Season ArrivesNovember 24th, 2022
- If the New COVID Variant Is Resistant to Immunity, Are the Vaccines and Boosters Worth It?July 19th, 2022
- Generic Hepatitis Drug Cost Savings Not Passed on to PatientsJune 26th, 2022
- Join now to see all
Grant Support
- Determining the performance and accuracy of SILVAMP TB LAM and cost-effectiveness of diagnostic testing for TB meningitisNIAID2022–2027
- Novel diagnostic development for TB meningitis and histoplasmosisNational Institutes of Neurologic Disorders and Stroke2019–2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: